• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Blood Collection and Processing Methods Affect Inflammatory Response in Vitro

October 3, 2018

Numerous studies have examined whether storage time affects the safety and quality of red blood cells (RBCs), but few studies have taken into account the collection and processing methods which may confound these results. In order to investigate differences in collection and processing methods, Almizraq and colleagues recently collected blood from donors using 4 different methods (n=8 per method):  (1) whole blood which was leukoreduced; (2) RBCs separated from whole blood by centrifugation and then leukoreduced; (3) RBCs collected using apheresis; and (4) whole blood with plasma extracted by centrifugation. Using an in vitro transfusion model, the cytokine profile of monocytes exposed to the 4 different types of blood product were then measured at days 5 and 42.  While immunomodulatory effects were largely independent of storage time, the cytokine profile of the monocytes differed based on the collection and processing method.  The RBCs collected via apheresis were immunosuppressive, while whole blood that was leukoreduced was inflammatory since the monocytes produced more interleukin-8.  The researchers also found the number and size of extracellular vesicles to differ based on the collection and processing method used; monocytes exposed to RBCs which were leukoreduced had fewer extracellular vesicles.  Further research is warranted in order to determine if blood collection and processing methods affect clinical outcomes after transfusion.

Reference:

  1. Almizraq RJ, Norris PJ, Inglis H, Menocha S, et al. Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity. Blood Advances 2018; 2(18);2296-2306.  

Filed Under

  • News
  • RBC Transfusion

Recommended

  • Larger Trial Needed to Confirm Restrictive versus Liberal Blood Transfusion Policies for Acute Upper Gastrointestinal Bleeding

  • Convalescent Plasma Is Safe and Likely Efficacious for Patients with COVID-19

  • HLA Induced Refractoriness to Platelet Transfusions

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Ferritin Levels Needed to Assess Hemoglobin Recovery after Blood Donation

  • Transfusion of RBCs from Cord Blood May Protect Low-Weight Preterm Infants from Severe Retinopathy

  • AABB Guidelines Recommend Liberal RBC Transfusion for Patients with Acute Myocardial Infarction

  • Artificial Intelligence to Predict Immunogenicity of Amino Acid Substitutions of Blood Group Antigens

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley